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Introduction 
Almotriptan  malate  (ATM)  is  a  serotonin  receptor 
agonist  used  in  the  acute  treatment  of  migraine 
headache in adults and adolescents aged from 12 to 17 
years  with  or  without  aura.
1-3  Chemically,  ATM  is 
known  as  1-[[[3-[2-(Dimethylamino)  ethyl]-1H-indol-
5-yl] methyl] sulfonyl] pyrrolidine malate (1:1). ATM 
stimulates  specific  serotonin  receptors  in  intracranial 
blood  vessels  and  sensory  trigeminal  nerves,  thereby 
promote vascular constriction and relieve migraine. 
A thorough literature survey has revealed that only a 
few liquid chromatographic methods are available for 
the  quantification  of  ATM  in  bulk,  pharmaceutical 
formulations  and  biological  fluids.  Assay  of 
almotriptan in pharmaceutical dosage forms by HPTLC 
has  been  reported  by  Suneetha  and  Syamasundar.
4 
Ravikumar et al.  have developed  LC-MS method  for 
the  determination  of  almotriptan  in  human  plasma.
5 
Nageswara Rao et al. have reported a LC-MS method 
for determining invivo metabolites of almotriptan in rat 
plasma, urine & faeces.
6 Jansat et al. and Fleishaker  et 
al. have reported HPLC method for the determination 
of  almotriptan  concentration  in  human  plasma  and 
urine, respectively.
7,8 
Only  two  HPLC  methods  with  UV  detection  were 
reported  in  the  literature  for  the  assay  of  ATM  in 
pharmaceutical dosage forms. In a method reported by 
Suneetha  and  Syamasundar,  separation  and 
quantification of ATM were conducted on Phenomenex 
Gemini  C18  column  using  potassium  dihydrogen 
phosphate buffer:acetonitrile (80:20) as a mobile phase. 
The  UV  detection  was  performed  at  227  nm.
9  Phani 
kumar  and  Sunandamma  have  reported  a  HPLC 
method using a Kromosil C18 column with a mobile 
phase  comprising  of  1%  Triethyl  amine:  acetonitrile: 
methanol  (05:55:40)  and  UV  detection  at  230  nm.
10 
The reported HPLC with UV detection methods suffer 
from the disadvantages such as narrow range of linear 
response,
9  longer  runtime  for  a  single  sample,
9,10 
preparation of  buffer,
9 strict  control  of pH,
9  and  less 
precise with RSD values greater than 1.5.
10  
The  present  paper  deals  with  the  development  and 
validation  of  a  RP-HPLC  method  with  UV  detection 
for the determination of ATM in bulk and tablet dosage 
forms. 
 
Materials and Methods  
Instrumentation  
Reverse Phase-High Pressure Liquid  Chromatography 
was performed with an isocratic High Pressure Liquid 
Chromatography  system  (Shimadzu  HPLC  class  VP 
series, Shimadzu Corporation, Kyoto, Japan) with two 
LC-10  AT,  VP  pumps,  variable  wavelength 
programmable  UV/Visible  detector  SPD-10A,  VP, 
CTO-10AS  VP  column  oven,  SCL-10A,  VP  system 
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Purpose:  A  simple  RP-HPLC  method  has  been  developed  and  validated  for  the 
determination  of  almotriptan  malate  (ATM)  in  bulk  and  tablets.  Methods: 
Chromatographic separation of ATM was achieved by using a Thermo Scientific C18 
column.  A  Mobile  phase  containing  a  mixture  of  methanol,  water  and  acetic  acid 
(4:8:0.1 v/v) was pumped at the flow rate of 1 mL/min. Detection was performed at 
227  nm.  According  to  ICH  guidelines,  the  method  was  validated.  Results:  The 
calibration curve was linear in the concentration range 5–60 µg/mL for the ATM with 
regression coefficient 0.9999. The method was precise with RSD <1.2%. Excellent 
recoveries  of  99.60  -  100.80%  proved  the  accuracy  of  the  method.  The  limits  of 
detection and quantification were found to be 0.025 and 0.075 μg/mL, respectively. 
Conclusion: The method was successfully applied for the quantification of ATM in 
tablets with acceptable accuracy and precision. 
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controller.  The  monitoring  software  was  “class  VP 
series  version  5.03”  (Shimadzu).  Separation  of  the 
ATM was achieved by using a 250 mm × 4.6 mm I.D., 
5  μm  particle  size,  Thermo  Scientific  C18 
(Phenomenex, Torrance,  CA,  USA)  column  under 
reversed-phase chromatographic conditions. 
 
Chemicals and Reagents 
All the chemicals were of HPLC grade quality. Milli-
Q-water was obtained from Merck Specialties Private 
Ltd,  Hyderabad,  India  and  used  right  throughout  the 
process. Methanol and glacial acetic acid were obtained 
from  Sd  fine  Chem  Limited,  Mumbai,  India. 
Pharmaceutical grade ATM was obtained from Matrix 
laboratories, Hyderabad, India. Branded ATM products 
(Axert tablets, Ortho-McNeil-Janssen Pharmaceuticals, 
Inc.  USA),  labeled  to  contain  6.25  and  12.5  mg  of 
ATM were purchased and used in the present study. 
 
Preparation of Mobile Phase 
The mobile phase was prepared by mixing methanol, 
water and glacial acetic acid in the ratio of 4:8:0.1 v/v. 
 
Preparation of Standard Drug Solutions 
For the stock standard solution (1 mg/mL), an exactly 
weighed 100 mg of ATM was dissolved and diluted to 
the  volume  with  the  mobile  phase  in  a  100  mL 
volumetric  flask.  Working  standard  solutions 
equivalent to 5 to 60 μg/mL of ATM were prepared by 
appropriate dilution of the stock standard solution with 
the mobile phase. 
 
Preparation of Tablet Extract 
Twenty tablets were weighed and finely powdered. A 
precisely weighed portion of the powder equivalent to 
100 mg of ATM was extracted with mobile phase. The 
extract was transferred to a 100 mL volumetric flask 
and made up to the mark with the mobile phase. The 
solution  was  filtered  through  a  0.45  μm  membrane 
filter. The tablet extract was appropriately diluted with 
mobile phase to obtain a concentration of 60 μg/mL.  
 
Chromatographic Conditions 
The  mobile  phase  [methanol,  water  and  acetic  acid 
(4:8:0.1 v/v)] was pumped at a flow rate of 1 mL/min. 
It  was  filtered  through  0.45  μm  membrane  filter  and 
degassed before using with a helium sparge for 15 min. 
The injection  volume  was  20  μL  and  the  eluent  was 
monitored  at  227  nm.  The  column  temperature  was 
25±1°C. 
 
Calibration Curve  
A series of working standard solutions prepared above 
were  taken.  Twenty  μl  aliquot  of  each  solution  was 
injected automatically into the column in triplicate. The 
peaks were determined at 227 nm. The mean peak are 
as versus concentrations of almotriptan were plotted to 
obtain the calibration curve. The seven concentrations 
of  the  working  standard  solution  were  subjected  to 
regression  analysis  to  calculate  regression  equation, 
slope,  intercept  and  regression  coefficient.  The 
concentration  of  the  drug  was  calculated  from  the 
calibration curve or the regression equation. 
 
Assay in Tablet Dosage Forms 
A  20  μl  aliquot  of  tablet  extract  (60  μg/mL)  was 
injected into the HPLC system in triplicate. The peaks 
were determined at 227 nm. The concentration of the 
drug  in  tablet  dosage  form  was  calculated  from  the 
calibration curve or the regression equation. 
 
Method Validation 
The  proposed  method  was  validated  for  system 
suitability,  linearity,  limit  of  detection,  limit  of 
quantification,  precision,  accuracy,  selectivity, 
robustness, ruggedness and stability of drug. 
 
System Suitability 
The study of system suitability was done to validate the 
sufficiency  of  the  reproducibility  of  chromatographic 
system for the analysis of ATM. This was carried out 
by five replicate analyses of the drug at a concentration 
of 60 μg/mL. The proposed method was evaluated by 
analyzing  the  parameters  like  retention  time,  peak 
asymmetry,  theoretical  plates,  plates  per  meter  and 
height equivalent to theoretical plate.  
 
Linearity 
For the assessment of linearity, determination of ATM 
was done at seven concentration levels (5, 10, 20, 30, 
40,  50  and  60  μg/mL).  Twenty  μl  aliquot  of  each 
concentration solution was injected automatically into 
the  column  in  triplicate  and  the  peak  areas  were 
recorded.  
 
Limit of Detection (LOD) and Limit of Quantification 
(LOQ) 
LOD and LOQ were calculated by using the following 
expressions: 
LOD = 3.3s / S 
LOQ = 10s / S 
Where “s” is the standard deviation of the regression 
line and “S” is the slope of calibration curve. 
 
Precision and Accuracy 
The  precision  and  accuracy  of  the  proposed  method 
was  assessed  by  intra-day  and  inter-day  variation 
studies using three different concentrations of ATM (5, 
30  and  60  μg/mL).  During  intra-day  studies,  five 
sample solutions of each concentration were analyzed 
on  the  same  day  whereas  inter-day  studies  were 
determined by analyzing five sample solutions of each 
concentration for three consecutive days.  
 
Recovery Studies 
Recovery  studies  were  performed  using  the  standard 
addition  method.  For  this  study,  a  known  amount  of 
pure  drug  was  added  to  the  preanalyzed  sample  
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solution.  Mean  percent  recovery  of  the  ATM  was 
determined. 
 
Selectivity 
Selectivity  was  assessed  by  examining  peak 
interferences  from  excipients  present  in  the  tablet 
dosage forms  and  components  of  mobile  phase.  This 
was  done  by  comparing  the  chromatograms  of  blank 
and tablet extract with the pure drug. 
 
Robustness 
To  verify  the  robustness  of  the  method,  three  vital 
experimental variables such as composition of mobile 
phase, detection wavelength and flow rate were slightly 
varied. The analysis was performed at the deliberately 
varied experimental conditions by taking two different 
concentrations of ATM (5 and 60 μg/mL) 
 
Ruggedness 
The method’s ruggedness was established by the deter-
mination of ATM at two different concentrations (5 and 
60  μg/mL).  This  was  performed  by  two  different 
analysts.  
 
Solution Stability  
To  assess  the  stability  of  ATM  in  mobile  phase,  the 
sample solutions (5 and 60 μg/mL) were prepared in 
the mobile phase and stored at room temperature for 48 
hr. The sample solutions were assayed at an interval of 
every 12 hr for 48 hr. 
 
Results and Discussion 
The  quantification  of  the  drugs  in  pharmaceutical 
dosage forms and biological fluids is necessary during 
the studies of stability, metabolism, pharmacokinetics, 
toxicity  and  drug  quality  control.  For  all  these 
investigations,  an  efficient  and  validated  analytical 
method is very significantly required.  
 
Method Development 
A reversed-phase C18, 250 mm × 4.6 mm I.D., 5 μm 
particle size column maintained at ambient temperature 
was  used  for  the  separation  of  ATM.  Regarding  the 
mobile phase, a mixture of methanol, water and glacial 
acetic acid was used. In order to improve the separation 
and peak symmetry, the mobile phase composition was 
varied until optimum composition was chosen (4:8:0.1 
v/v). Isocratic elution at the flow rate of 1.0 mL/min has 
been  employed  in  the  present  proposed  method. 
Wavelength of 227 nm was chosen to be used for the 
UV detection. The column is kept at room temperature 
during  the  procedure.  After  this  optimization,  this 
method has been used for the assay of ATM. A good 
separation  with  satisfactory  resolution  has  been 
obtained (Figure 1). 
 
 
 
Figure 1. Representative chromatogram of pure ATM (a), tablet extract (b) and blank mobile phase. 
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Validation 
System Suitability 
The system suitability parameters, like retention time, 
peak  asymmetry,  theoretical  plates,  plates  per  meter 
and  height  equivalent  to  theoretical  plate  were 
calculated. From the results (Table 1), it was observed 
that all the values are within the limits.  
 
Table 1. System suitability studies. 
Parameter  Value  RSD (%) 
Retention Time (t) (Min)  4.692  0.052 
Theoretical Plates (n)  4832.82  1.06 
Plates per Meter (N)  16100  1.113 
Height equivalent to theoretical 
plate (HETP) (mm) 
6.2x10
-7  1.021 
Peak asymmetry  1.16  1.071 
RSD: Relative standard deviation 
 
Linearity 
Linear  relationship  was  observed  by  plotting 
concentrations  of  the  drug  against  peak  areas.  ATM 
exhibited linear response in the concentration range, 5 
to  60  μg/mL.  The  corresponding  linear  regression 
equation  was  y  =  53532x  +  39.216  with  regression 
coefficient (R
2) 0.9999.  
 
The  Llimit  of  Detection  (LOD)  and  Limit  of 
Quantification (LOQ)  
LOD  and  LOQ  of  the  proposed  method  were 
determined as s/S ratio 3.3 for LOD and 10 fold for 
LOQ. The low values of LOD and LOQ, that is, 0.025 
and  0.075  μg/mL,  respectively  suggest  the  high 
sensitivity of the method. 
 
Precision and Accuracy 
The relative standard deviation for intra-day and inter-
day analysis was in the range of 0.129 to 0.823 % and 
0.822 to 1.170 %, respectively. Mean recovery of ATM 
using the proposed method was in the range of 99.60-
100.30 (intra-day analysis) and 99.76–100.80 (inter-day 
analysis).  The  results  point  out  the  precision  and 
accuracy of the method developed (Table 2). 
 
Table 2. Precision and accuracy of the method. 
Assay type 
Concentration of ATM (µg/mL)  RSD 
(%) 
Recovery 
(%)  Taken  Recovered ± SD* 
Intra-day 
5  4.98 ± 0.041  0.823  99.60 
30  30.09 ± 0.052  0.175  100.30 
60  60.04 ± 0.092  0.129  100.06 
Inter-day 
5  5.04 ± 0.059  1.170  100.80 
30  29.93 ± 0.298  0.995  99.76 
60  59.95 ± 0.493  0.822  99.91 
*Average  of  five  determinations;  SD:  Standard  deviation; 
RSD: Relative standard deviation 
Recovery Studies 
Preanalyzed  sample  solution  was  spiked  with  pure 
ATM  and  then  the  total  amount  of  ATM  was 
determined by the proposed method. The results (Table 
3) showed that the mean recovery and relative standard 
deviation  were  in  the  range  of  99.97–100.09  %  and 
0.799-0.973%, respectively. From the recovery study it 
was apparent that the proposed method is very accurate 
for quantitative determination of ATM in tablet dosage 
form. The excipients and additives commonly present 
in the tablet dosage forms did not interfere in the assay. 
 
Table 3. Results of recovery studies. 
Concentration of ATM (mg)  RSD 
(%) 
Recovery 
(%)  Tablet  Spiked  Recovered ± SD* 
6.25  3.0  9.248 ± 0.090  0.973  99.97 
12.50  6.25  18.766± 0.150  0.799  100.09 
*  Average  of  five  determinations  ,  SD:  Standard  deviation, 
RSD: Relative standard deviation 
 
Selectivity 
The selectivity of  the proposed method  demonstrated 
that  excipients  in  the  tablet  dosage  forms  and 
components of mobile phase did not interfere with the 
drug  peak.  In  addition,  the  well  shaped  peaks  also 
signify the selectivity of the proposed method (Figure 1). 
 
Robustness 
Robustness  of  the  proposed  method  was  assessed  by 
making  small  changes  in  the  composition  of  mobile 
phase, detection wavelength and flow rate. The small 
variations in any of the variables did not significantly 
affect the results (Table 4). The lower values of RSD 
(<1.3%)  demonstrate  the  excellent  robustness  of  the 
proposed method.  
 
 
Table 4. Robustness of the method. 
Experimental 
parameter 
Concentration of ATM (µg/mL)  RSD 
(%)  Taken  Recovered ± SD
$ 
Mobile phase
*  5  5.05 ± 0.021  0.415 
60  59.97 ± 0.324  0.540 
Detection wavelength
**  5  5.02 ± 0.036  0.717 
60  59.90 ± 0.466  0.777 
Flow rate
***  5  4.96 ± 0.063  1.270 
60  60.01 ± 0.514  0.856 
*Methanol,  water  and  acetic  acid  ratios  (v/v):  3.9:8.1:0.1, 
4:8:0.1, 4.1:7.9:0.1 
**Wavelength (nm) – 226,227 and 228 
***Flow rate (mL/min) – 0.9, 1.0 and 1.1 
$Average of three determinations 
SD- Standard deviation 
RSD- Relative standard deviation  
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Ruggedness 
Ruggedness of the method was performed by analyzing 
5  and  60  μg/mL  of  ATM  by  two  different  analysts 
keeping same experimental conditions. The results are 
presented in Table 5. The lower values of RSD (<1.0%) 
confirm the ruggedness of the proposed method. 
 
Table 5. Ruggedness of the method 
Analyst 
Concentration of ATM (µg/mL) 
SD**  RSD (%) 
Taken  Recovered
* 
I
  5  4.96 
±0.042  0.841 
II  5  5.02 
I
  60  59.90 
±0.056  0.093 
II  60  59.98 
* Average of five determinations, ** Standard deviation for 
two  values,  SD:  Standard  deviation,  RSD:  Relative 
standard deviation 
 
Solution Stability 
Relative standard deviation for assay of ATM during 
solution  stability  was  <1.0%  (Table  6).  The  results 
from  solution  stability  experiments  confirmed  that 
ATM in the mobile phase was stable for up to 48 hr.  
 
Table 6. Stability of ATM in mobile phase 
Time (hr) 
Concentration of ATM (µg/mL) 
SD**  RSD (%) 
Taken  Recovered
* 
12
  5  5.05 
±0.044  0.880 
24  5  5.02 
36
  5  4.98 
48  5  4.95 
12
  60  60.05 
±0.062  0.103 
24  60  59.95 
36
  60  59.97 
48  60  59.90 
* Average of five determinations, ** Standard deviation for 
four values, SD: Standard deviation, RSD: Relative standard 
deviation 
 
Application to Tablet Dosage Forms 
The proposed method was effectively applied for the 
quantification of ATM in two different dosage forms. 
The results, shown in Table 7, are in good agreement 
with  those  obtained  with  the  reference  UV 
spectrophotometric method.
11 
 
Conclusion 
The proposed HPLC method was found to be simple, 
precise, accurate and rapid for the estimation of ATM 
in bulk and in its dosage forms. The mobile phase is 
simple to prepare. The sample recoveries in all tablet 
dosage  forms  were  in  good  agreement  with  their 
respective labelled claim and suggested noninterference 
of  tablet  excipients  in  the  estimation.  Hence,  this 
method  can  be  easily  and  conveniently  adopted  for 
routine analysis of ATM in quality control laboratories.  
 
Table 7. Results of analysis of ATM in tablets 
Formulation  Method 
Concentration of ATM (mg) 
Tablet  Recovered ± SD** 
Tablet* 
Reference 
6.25 
6.246 ± 0.014 
% R=99.93 
% RSD=0.224 
12.50 
12.504 ± 0.024 
% R=100.09 
% RSD=0.194 
Proposed 
HPLC method 
6.25 
6.249 ± 0.054 
% R=99.98 
% RSD=0.863 
t Value
$= 1.19 
F value
$$=3.29 
12.50 
12.490 ± 0.120 
% R=99.92 
% RSD=0.960 
t Value
$= 1.11 
F value
$$=4.66 
*Axert tablets, Ortho-McNeil-Janssen Pharmaceuticals, Inc. 
USA 
** Average of five determinations 
%R – Percentage recovery 
% RSD – Percentage relative standard deviation 
$ Tabulated t-value at 95% confidence level is 2.306 
$$ Tabulated F- value at 95 % confidence level is 6.390 
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